Loading…

Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion

Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion Xiaoshun Liu, Yanming Huang, Peter Pokreisz, Pieter Vermeersch, Glenn Marsboom, Marc Swinnen, Eric Verbeken, Jose Santos, Marijke Pellens, Hilde Gillijns, Frans Van de Werf, Ke...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2007-08, Vol.50 (8), p.808-817
Main Authors: Liu, Xiaoshun, MD, PhD, Huang, Yanming, MD, PhD, Pokreisz, Peter, PhD, Vermeersch, Pieter, MD, Marsboom, Glenn, MSc, Swinnen, Marc, Verbeken, Eric, MD, PhD, Santos, Jose, MD, Pellens, Marijke, Gillijns, Hilde, Van de Werf, Frans, MD, PhD, Bloch, Kenneth D., MD, Janssens, Stefan, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nitric Oxide Inhalation Improves Microvascular Flow and Decreases Infarction Size After Myocardial Ischemia and Reperfusion Xiaoshun Liu, Yanming Huang, Peter Pokreisz, Pieter Vermeersch, Glenn Marsboom, Marc Swinnen, Eric Verbeken, Jose Santos, Marijke Pellens, Hilde Gillijns, Frans Van de Werf, Kenneth D. Bloch, Stefan Janssens This study tested whether or not inhaled nitric oxide (iNO) could improve microvascular perfusion and decrease tissue injury in a porcine model if myocardial ischemia and reperfusion. Pigs were treated with a saline infusion (n = 14), intravenous nitroglycerin at 2 μg/kg/min (n = 11), or iNO at 80 parts per million (n = 12), beginning 10 min before the end of a 50-min LAD balloon occlusion period and continuing throughout a 4-h reperfusion period. Inhalation of NO significantly improves microvascular perfusion, decreases leukocyte activation and cardiomyocyte apoptosis, and reduces infarct size, and may offer an attractive and novel treatment of myocardial infarction.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2007.04.069